These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 20173368)
1. Urine cytology in the evaluation of urological malignancy revisited: is it still necessary? Falebita OA; Lee G; Sweeney P Urol Int; 2010; 84(1):45-9. PubMed ID: 20173368 [TBL] [Abstract][Full Text] [Related]
2. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer. Kumar A; Kumar R; Gupta NP Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289 [TBL] [Abstract][Full Text] [Related]
6. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder. Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567 [TBL] [Abstract][Full Text] [Related]
7. The fate of an unsatisfactory urine cytology test among patients with urothelial carcinoma. Ordon M; Boerner S; Zlotta AR; Jewett MA; Fleshner N BJU Int; 2009 Dec; 104(11):1641-5. PubMed ID: 19583723 [TBL] [Abstract][Full Text] [Related]
8. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193 [TBL] [Abstract][Full Text] [Related]
9. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology. Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151 [TBL] [Abstract][Full Text] [Related]
10. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813 [TBL] [Abstract][Full Text] [Related]
11. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice. May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921 [TBL] [Abstract][Full Text] [Related]
12. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method? Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859 [TBL] [Abstract][Full Text] [Related]
13. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings. Bergman J; Reznichek RC; Rajfer J BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536 [TBL] [Abstract][Full Text] [Related]
15. Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer. Parekattil SJ; Fisher HA; Kogan BA J Urol; 2003 Mar; 169(3):917-20. PubMed ID: 12576812 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma. Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379 [TBL] [Abstract][Full Text] [Related]
17. Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer?--experience at Kuwait University. Kapila K; Kehinde EO; Anim JT; Mojiminiyi OA; Vinsu A; George SS; Al-Maghrebi M; Al-Mulla F Cytopathology; 2008 Dec; 19(6):369-74. PubMed ID: 18631356 [TBL] [Abstract][Full Text] [Related]
18. The dilemma of suspicious urine cytology in patients being followed for bladder cancer. Raitanen MP; Aine R; Kylmälä T; Kallio J; Liukkonen T; Tammela T; Ann Chir Gynaecol; 2001; 90(4):256-9. PubMed ID: 11820413 [TBL] [Abstract][Full Text] [Related]
19. Is cytology required for a hematuria evaluation? Hofland CA; Mariani AJ J Urol; 2004 Jan; 171(1):324-6. PubMed ID: 14665906 [TBL] [Abstract][Full Text] [Related]
20. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive? Raitanen MP; Aine RA; Kaasinen ES; Liukkonen TJ; Kylmälä TM; Huhtala H; Tammela TL; Scand J Urol Nephrol; 2002; 36(3):213-7. PubMed ID: 12201938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]